Meanwhile, several studies have been conducted on the relationship between circulating irisin level and disease severity of NAFLD and demonstrated that the irisin level in mild steatosis patients was higher than that in moderate and severe steatosis patients. The gene discussed is FNDC5; the disease is metabolic dysfunction-associated steatotic liver disease.